NETEC COVID-19 Webinar Series

Pandemic Related Consent, Research and Ethics

Release Date: 12/04/2020

Expires: 12/03/2021

The estimated time to complete this enduring material is 60 minutes.

TARGET AUDIENCE

This enduring material is intended primarily for healthcare workers and teams which may include but are not limited to, medical and nursing staff, administration, education/training leadership, and infection control leadership. Staff specializing in emergency management, communications, specialized clinical areas, laboratory, facilities management and environmental services are also welcome.

EDUCATIONAL OBJECTIVES

At the conclusion of this enduring material, the participant should be better able to:

• Discuss the challenges involved when obtaining informed consent from a hospitalized patient who is in isolation related to COVID-19.
• Articulate the obstacles and strategies involved when conducting research during a pandemic based on case-based ethical scenarios.
• Describe ethical considerations regarding clinical care in the context of COVID-19.

FACULTY AND PLANNING COMMITTEE DISCLOSURES

The following faculty** and planning committee members have no financial relationships to disclose.

• Sarah Anderson-Fiore, MPH, CHES
• Christa Arguinchona, MSN, BSN, RN, CCRN**
• Sonia Bell, BS
• Joseph Carrese, MD, MPH, FACP**
• Heidi Keeler, PhD, RN
• Allison Klajbor, BS
• LuAnn Larson, RN, CCRP**
• Benjamin Mattson, MS Ed
• Vikram Mukherjee, MD**
• Jason Noble, BA, BFA
• Renee Paulin, MSN, RN, CWOCN
• Brenda Ram, CMP, CHCP
• Michelle Schwedhelm, MSN, RN, NEA-BC
• Patricia Tennill, BSN, RN**
• Sharon Vanairsdale, DNP, APRN, ACNS-BC, NP-C, CEN. FAEN, FAAN
• Sami Vasistha, MS

The following faculty member has disclosed the following relationships:

Jeremy Sugarman, MD, MPH, MA***

Advisory Committee/Board: Merck, IQVIA, Aspen Neurosciences

Consultant: Biogen, Portola Pharmaceuticals

FINANCIAL SUPPORT

This program is funded by ASPR & CDC